Table 3

Percentage of adults with asthma who switched, stepped-down or stepped-up respiratory pharmacological treatment after the first-line treatment (broad definition)

LabelCCAE (USA)Medicaid (USA)Medicare (USA)EHIF (Estonia)CPRD (UK)SIDIAP (Spain)IPCI
(The Netherlands)
AUSOM
(South Korea)
Step-up13.111.912.020.623.921.017.614.3
Step-down9.06.67.723.016.717.59.919.5
Switching9.77.99.511.827.817.211.26.0
Start of acute exacerbation20.120.918.310.66.512.412.114.3
End of acute exacerbation15.914.915.93.34.68.48.114.9
No follow-up treatment*32.037.536.029.919.120.638.430.6
Other0.20.30.50.81.42.82.70.4
  • *Patients who did not receive medication of a different respiratory drug class after the first treatment, that is, patients who remained on the same treatment or who discontinued treatment.